Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Noam Ringer. (2020) Living with ADHD: A Meta-Synthesis Review of Qualitative Research on Children’s Experiences and Understanding of Their ADHD. International Journal of Disability, Development and Education 67:2, pages 208-224.
Read now
Read now
Bilge Kara, Nilfer Sahin, Murat Kara, Esin Sakalli Cetin & Hatice Topal. (2018) The relationship between attention deficit hyperactivity disorder and reelin gene polymorphisms in Turkish population. Psychiatry and Clinical Psychopharmacology 28:4, pages 423-428.
Read now
Read now
Renata Rizzo & Davide Martino. (2015) Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Expert Review of Neurotherapeutics 15:4, pages 347-354.
Read now
Read now
Katrin Luise Laezer. (2015) Effectiveness of Psychoanalytic Psychotherapy and Behavioral Therapy Treatment in Children with Attention Deficit Hyperactivity Disorder and Oppositional Defiant Disorder. Journal of Infant, Child, and Adolescent Psychotherapy 14:2, pages 111-128.
Read now
Read now
John S Markowitz & Bryan J Brinda. (2014) A pharmacokinetic evaluation of oral edivoxetine hydrochloride for the treatment of attention deficit-hyperactivity disorder. Expert Opinion on Drug Metabolism & Toxicology 10:9, pages 1289-1299.
Read now
Read now
Articles from other publishers (21)
Jeff Schein, Ann Childress, Julie Adams, Patrick Gagnon-Sanschagrin, Jessica Maitland, Wendi Qu, Martin Cloutier & Annie Guérin. (2022) Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States – a retrospective claims analysis. BMC Psychiatry 22:1.
Crossref
Crossref
John S. Markowitz & Philip W. Melchert. (2022) The Pharmacokinetics and Pharmacogenomics of Psychostimulants. Child and Adolescent Psychiatric Clinics of North America 31:3, pages 393-416.
Crossref
Crossref
Nayla M. Khoury, Nevena V. Radonjić, Avery B. Albert & Stephen V. Faraone. (2022) From Structural Disparities to Neuropharmacology. Child and Adolescent Psychiatric Clinics of North America 31:3, pages 343-361.
Crossref
Crossref
Nikolaos Kotsanos, Luc A. M. Marks, Konstantinos N. Arapostathis & Kazumi Kubota. 2022. Pediatric Dentistry. Pediatric Dentistry
527
552
.
Azizollah Mojahed, Youns Zaheri & Mahboobeh Firoozkoohi Moqaddam. (2021) Effectiveness of group psychodrama on aggression and social anxiety of children with attention-deficit/hyperactivity disorder: A randomized clinical trial. The Arts in Psychotherapy 73, pages 101756.
Crossref
Crossref
Xiaoqiang Xiang & Yawen Yuan. 2020. Pharmacogenomics in Precision Medicine. Pharmacogenomics in Precision Medicine
257
276
.
Sharlene Kaye, Josep Antoni Ramos-Quiroga, Geurt van de Glind, Frances R. Levin, Stephen V. Faraone, Steve Allsop, Louisa Degenhardt, Franz Moggi, Csaba Barta, Maija Konstenius, Johan Franck, Arvid Skutle, Eli-Torild Bu, Maarten W. J. Koeter, Zsolt Demetrovics, Máté Kapitány-Fövény, Robert A. Schoevers, Katelijne van Emmerik-van Oortmerssen, Pieter-Jan Carpentier, Geert Dom, Sofie Verspreet, Cleo L. Crunelle, Jesse T. Young, Susan Carruthers, Joanne Cassar, Melina Fatséas, Marc Auriacombe, Brian Johnson, Matthew Dunn, Ortal Slobodin & Wim van den Brink. (2016) Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers. Journal of Attention Disorders 23:12, pages 1438-1453.
Crossref
Crossref
Amber D. Hunt, David W. Dunn, Hillary S. Blake & Jennifer Downs. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry
215
235
.
Emily J. RickettsAlexandra SturmDana L. McMakinJoseph F. McGuirePatricia Z. TanFallon B. SmalbergJames T. McCrackenChristopher S. ColwellJohn Piacentini. (2018) Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study. Journal of Child and Adolescent Psychopharmacology 28:10, pages 690-698.
Crossref
Crossref
Julian Schöllkopf, Sandra Unholzer & Ekkehard Haen. (2017) Guanfacin — vom Blutdrucksenker zum Mittel der Wahl bei ADHS?. NeuroTransmitter 28:5, pages 34-37.
Crossref
Crossref
Emuella Flood, Kavita Gajria, Vanja Sikirica, Paul Hodgkins, M. Haim Erder, Frank Lopez & Daniel Connor. (2016) Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers. Journal of Health Economics and Outcomes Research 3:1, pages 56-72.
Crossref
Crossref
Alexander K.C. Leung & Kam Lun Hon. (2016) Attention-Deficit/Hyperactivity Disorder. Advances in Pediatrics 63:1, pages 255-280.
Crossref
Crossref
Guo YuGuo-Fu LiJohn S. Markowitz. (2016) Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition. Journal of Child and Adolescent Psychopharmacology 26:4, pages 314-326.
Crossref
Crossref
Michael Huss, Wai Chen & Andrea G. Ludolph. (2015) Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe. Clinical Drug Investigation 36:1, pages 1-25.
Crossref
Crossref
John S. Markowitz & Guo Yu. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
303
327
.
Els van den Ban. (2015) ADHD-medicatie, meer en langduriger gebruikt. Huisarts en wetenschap 58:7, pages 362-364.
Crossref
Crossref
William P. French. (2015) Assessment and Treatment of Attention-Deficit/Hyperactivity Disorder: Part 2. Pediatric Annals 44:4, pages 160-168.
Crossref
Crossref
Rana Ahmed, David K Raynor, Kirsten J McCaffery & Parisa Aslani. (2014) The design and user-testing of a question prompt list for attention-deficit/hyperactivity disorder. BMJ Open 4:12, pages e006585.
Crossref
Crossref
Stephen V. Faraone & Kevin M. Antshel. (2014) Towards an Evidence-based Taxonomy of Nonpharmacologic Treatments for ADHD. Child and Adolescent Psychiatric Clinics of North America 23:4, pages 965-972.
Crossref
Crossref
Florence T. Bourgeois, Jeong Min Kim & Kenneth D. Mandl. (2014) Premarket Safety and Efficacy Studies for ADHD Medications in Children. PLoS ONE 9:7, pages e102249.
Crossref
Crossref
Amy B. HartEric R. Gamazon, Barbara E. EngelhardtPamela SklarAnna K. KählerChristina M. HultmanPatrick F. SullivanBenjamin M. Neale, Stephen V. Faraone, Harriet de WitNancy J. Cox, Abraham A. PalmerRichard Anney, Philip Asherson, Tobias Banaschewski, Mònica Bayés, Joseph Biederman, Jan K. Buitelaar, Miquel Casas, Bru Cormand, Jennifer Crosbie, Alysa E. Doyle, Josephine Elia, Stephen V. Faraone, Barbara Franke, Lindsey Kent, Jonna Kuntsi, Klaus-Peter Lesch, Sandra K. Loo, James J. McGough, Sarah E. Medland, Benjamin Neale, Stan F. Nelson, Robert D. Oades, Josep Antoni Ramos-Quiroga, Andreas Reif, Marta Ribasés, Aribert Rothenberger, Russell Schachar, Susan L. Smalley, Edmund Sonuga-Barke, Hans-Christoph Steinhausen, Anita Thapar & Nigel Williams. (2014)
Genetic variation associated with euphorigenic effects of
d
-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder
. Proceedings of the National Academy of Sciences 111:16, pages 5968-5973.
Crossref
Crossref